Cellular Origin Constellation News Today

Cellular Origins and the Cell and Gene Therapy Catapult (CGT Catapult) have announced a new collaboration to demonstrate universal automation of CGT manufacturing.

Partnership to develop and implement Cellular Origins' robotic platform Constellation for universal automation of CGT manufacturing at CGT Catapult's Stevenage Manufacturing Innovation Centre Cellular

Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), and the Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organisation specializing in the advancement of the cell and gene therapy industry, today announced a collaboration to demonstrate universal automation of CGT manufacturing.